https://diy.parentprojectmd.org/fibrogen-announces-topline-data-from-phase-3-lelantos-2-study/
FibroGen Announces Topline Data from Phase 3 LELANTOS-2 Study - DIY Fundraising
May 20, 2026 - FibroGen has announced topline results of the Phase 3 LELANTOS-2 trial of pamrevlumab, their investigational anti-fibrotic monoclonal antibody, for ambulatory...
data from
https://www.lelantostech.com/
Lelantos
https://lelantospress.com/
Lelantos
Based in Brooklyn NY, Lelantos publishes fairy tales, fantasy, and speculative reverie.